Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 7Recruiting 4Withdrawn 2Unknown 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Renal Cell 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Optical Imaging × Clear all
NCT01104389 2015-08-26

Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging

Intuitive Surgical

Phase NA Withdrawn
Genitourinary

Carcinoma, Renal Cell

NCT01688414 2014-07-29

Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer

Stanford University

Phase NA Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡